Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Sainte-Foy-Les-Lyon

6 clinical trials in Sainte-Foy-Les-Lyon, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Sainte-Foy-Les-Lyon at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Sainte-Foy-Les-Lyon

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Institut Gustave Roussy
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Sainte-Foy-Les-Lyon

What the registry says about research in the country

01 Gastrointestinal Oncology

Innovative research focusing on rectal adenocarcinoma treatment, exploring advanced preservation techniques through specialized radiation therapy. These trials aim to improve organ preservation outcomes for patients with intermediate-risk rectal cancer.

  • Contact X-ray Brachytherapy Studies
  • Total Neoadjuvant Therapy Evaluation
  • Colon Cancer Treatment Optimization

Additional studies investigate circulating tumor DNA analysis for personalizing colon cancer treatment decisions.

02 Breast Cancer Research

Comprehensive studies examining innovative approaches for HER2-positive breast cancer treatment, including investigation of targeted therapies and their interactions with support medications.

  • Hormone Therapy Optimization
  • Targeted Treatment Effectiveness
  • Post-menopausal Treatment Strategies

Research focuses on reducing treatment duration while maintaining efficacy for specific patient populations.

03 Precision Medicine Initiatives

Advanced research implementing biomarker-driven approaches to personalize cancer treatment strategies, particularly in breast and colorectal cancers.

  • Molecular Profiling Studies
  • Treatment Duration Optimization
  • Risk-Adapted Therapy Protocols

These trials aim to identify patients who can benefit from modified treatment schedules based on specific disease characteristics.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.